pretickt

LH financials

Labcorp Holdings Inc. · end-of-day data as of Oct 16, 2026

Labcorp Holdings Inc.
LH · $25.79B
$317.95+7.4%last 60 sessions · close Oct 16, 2026
$244.17$338.6152 weeks
Buy · 18 analystsPT $336.42 +5.8%
  • P/E vs own+6.3%
  • P/E vs sector-6.6%
  • Target upside+5.8%
  • Off 52w high-6.1%
  • Insiders-$3.17M
  • FCF yield+4.5%
  • Earnings in12d
  • Trendbullish
  • Sector▲ +16.0%
  • RSI53
  • MA20×50—
  • Volume1.0x
  • Support-4.0%
  • Resistance+1.0%

LH reported revenue of $3.73B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 5.8% from a year earlier. It posted diluted EPS of $3.64, free cash flow of $314M and a net margin of 8.0%.

Valuation

  • P/E26.3x
  • P/E vs own+6.3%
  • P/E vs sector-6.6%
  • FCF yield+4.5%
  • Market cap$25.79B

Quarterly results

Q2 FY2026: Revenue +5.8% year over year, free cash flow 8.4% of revenue, operating margin 12.1%.

RevenueFree cash flow
Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$3.73B3.64$314M29.8%12.1%8.0%
Q1 FY2026Mar 31, 2026$3.54B3.35$70.5M26.5%10.9%7.9%
Q4 FY2025Dec 31, 2025$3.52B1.98$490M26.2%10.9%4.7%
Q3 FY2025Sep 30, 2025$3.56B3.12$281M28.8%11.1%7.3%
Q2 FY2025Jun 30, 2025$3.53B2.84$543M29.7%11.2%6.7%
Q1 FY2025Mar 31, 2025$3.35B2.52-$108M28.3%9.7%6.4%
Q4 FY2024Dec 31, 2024$3.33B1.70$665M26.9%6.5%4.3%
Q3 FY2024Sep 30, 2024$3.28B2.01$162M27.6%7.7%5.2%
Q2 FY2024Jun 30, 2024$3.22B2.44$433M28.8%9.2%6.4%
Q1 FY2024Mar 31, 2024$3.18B2.69-$164M28.2%10.1%7.2%
Q4 FY2023Dec 31, 2023$3.03B-1.97$412M27.1%-4.0%-5.5%
Q3 FY2023Sep 30, 2023$3.06B2.11$171M27.8%8.3%6.0%